<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="abstract" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Crit Care</journal-id><journal-id journal-id-type="iso-abbrev">Crit Care</journal-id><journal-title-group><journal-title>Critical Care</journal-title></journal-title-group><issn pub-type="ppub">1364-8535</issn><issn pub-type="epub">1466-609X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmc">4471159</article-id><article-id pub-id-type="publisher-id">cc14158</article-id><article-id pub-id-type="doi">10.1186/cc14158</article-id><article-categories><subj-group subj-group-type="heading"><subject>Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Use of nanotechnology-based surface antiseptic solutions in the ICU</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="A1"><name><surname>Kuplay</surname><given-names>Y</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A2"><name><surname>Akgun</surname><given-names>N</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A3"><name><surname>Agalar</surname><given-names>C</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A4"><name><surname>Ayd&#x000fd;n</surname><given-names>H</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A5"><name><surname>Al&#x000fd;c&#x000fd;</surname><given-names>O</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib><contrib contrib-type="author" id="A6"><name><surname>Turan</surname><given-names>G</given-names></name><xref ref-type="aff" rid="I1">1</xref></contrib></contrib-group><aff id="I1"><label>1</label>FSM Teaching and Research Hospital, Istanbul, Turkey</aff><pub-date pub-type="ppub"><year>2015</year></pub-date><pub-date pub-type="epub"><day>16</day><month>3</month><year>2015</year></pub-date><volume>19</volume><issue>Suppl 1</issue><supplement><named-content content-type="supplement-title">35th International Symposium on Intensive Care and Emergency Medicine</named-content><named-content content-type="supplement-sponsor">Pubication charges for this supplement were funded by ISICEM.</named-content></supplement><fpage>P78</fpage><lpage>P78</lpage><permissions><copyright-statement>Copyright &#x000a9; 2015 Kuplay et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder>Kuplay et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://ccforum.com/content/19/S1/P78"/><conference><conf-date>17-20 March 2015</conf-date><conf-name>35th International Symposium on Intensive Care and Emergency Medicine</conf-name><conf-loc>Brussels, Belgium</conf-loc></conference></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>In our study, we aimed to compare the application of benzalkonium chloride (BC) - a nanotechnology-based product - for 24-hour periods and didecyl dimethyl ammonium chloride (DDAC) for 12-hour periods regarding efficiency in application of surface antiseptics in the ICU.</p></sec><sec sec-type="methods"><title>Methods</title><p>Two different areas with eight beds at both sides of a common corridor in the ICU were named as areas A and B. BC was applied in area A with 24-hour periods and DDCA was applied in area B with 12hour periods for surface cleaning. Samples were taken from a total of 20 different surfaces including nurse-station desks, phones, keyboards, beds, bedside monitors and ventilators by the same infection control nurse every 24 hours from area A and every 12 hours from area B for 7 days. Swab samples were cultured on 5% sheep bloody agar and McConkey agar in the laboratory. Then the cultured mediums were incubated at 35 to 37&#x000b0;C in an aerobic environment for 18 to 24 hours. NCSS (Number Cruncher Statistical System) 2007 and PASS 2008 Statistical Software (UT, USA) program were used for the statistical analysis.</p></sec><sec sec-type="results"><title>Results</title><p>There were no statistical differences between two groups (Table <xref ref-type="table" rid="T1">1</xref>).</p><table-wrap id="T1" position="float"><label>Table 1</label><caption><p>Isolated pathogen ratio percentage</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th align="center">A (BC)</th><th align="center">B (DDCA) </th><th align="center"><italic>P </italic>value </th></tr></thead><tbody><tr><td align="left">First day</td><td align="center">25</td><td align="center">20</td><td align="center">1.000</td></tr><tr><td align="left">Second day</td><td align="center">5</td><td align="center">15</td><td align="center">0.605</td></tr><tr><td align="left">Third day</td><td align="center">30</td><td align="center">20</td><td align="center">0.715</td></tr><tr><td align="left">Fourth day</td><td align="center">65</td><td align="center">50</td><td align="center">0.527</td></tr><tr><td align="left">Fifth day</td><td align="center">45</td><td align="center">60</td><td align="center">0.527</td></tr><tr><td align="left">Sixth day</td><td align="center">25</td><td align="center">25</td><td align="center">1.000</td></tr><tr><td align="left">Seventh day</td><td align="center">60</td><td align="center">45</td><td align="center">0.527</td></tr></tbody></table></table-wrap></sec><sec sec-type="conclusions"><title>Conclusion</title><p>The effect of a good surface disinfectant should begin immediately and it should have a long-lasting disinfecting effect on the surface. DDAC is an efficient disinfectant used in medicine and the food industry to protect the surfaces. However, it may cause severe skin itching. BC, which is a nanotechnology-based product, leaves its active metabolites on the surface; it is applied by constituting a spongy layer. Since the efficiency of BC lasts for 24 hours and it is applied to perform cleaning with 24-hour intervals, we think that it is preferable with regards to workforce gain and cost.</p></sec></body></article>